CURRICULUM

The Pharma MBA offers a unique learning experience combining online flexibility and on-campus engagement. We've reimagined the traditional classroom to allow you to study and prepare from home while providing dynamic in-person campus interactions. Our flipped classroom approach allows you to access lessons and materials online, empowering you to learn at your own pace. This sets the stage for enriching in-class discussions, collaborations, and hands-on experiences that enhance your understanding of the subject matter.

We understand that your time is valuable. That's why we minimize the need for frequent travel to campus, enabling you to balance your education and work commitments better – alongside your job in only four semesters!

  • Semesters 1-3: Lectures on Friday afternoons (13:00 to 20:00) and Saturdays (9:00 to 17:00) on 8-10 weekends, final module exams included
  • Semester 4: Preparatory seminar and final master thesis; no regular on-campus attendance is required. The module “Ethics and Diversity” concludes the on-campus phase and takes place at the beginning of the semester.

Learn more about our faculty and the experts behind the program.

The purpose of this example is to provide an initial overview for prospective students. The dates may vary by semester.

SEMESTER DATES
Orientation Days October 4 - 5
Lectures October 6 - 7
Lectures October 20 - 21
Lectures November 3 - 4
Lectures November 17 - 18
Exam December 1
Lectures December 15 - 16
Lectures January 12 - 13
Lectures January 26 - 28
Lectures February 2 - 3
Lectures February 9 - 10
Exams February 23

The lecture-free period begins after completing the exams and ends with the start of the new semester (April/October). 

MODULAR CURRICULUM

Build a strong foundation in modern management and leadership and apply these skills within the pharmaceutical industry's professional context.

  • Strategic Management  & Corporate Development
  • Finance & Accounting
  • Managing People
  • Managing the Pharmaceutical Value Chain
  • Ethics & Diversity (Sem. 4)

Expand your perspective and select four modules within the pharmaceutical value chain based on your personal and professional preferences.

Apply the knowledge gained in the program and address a real-world problem, ideally from your own experience or company. A preparatory seminar will help you to learn the necessary scientific methods.

NETWORKING & WORKSHOPS

INDUSTRY EXPERTS

The Pharma MBA connects students with leading professionals shaping the future of the pharmaceutical and healthcare industries. Through workshops, guest lectures, and collaborative formats, they provide valuable industry insights and strengthen the program’s practical relevance.

Dr. Christoph Bug, MD, PhD, MBA

VP Global Medical
Veeva Systems

LL.M Susanna Dienemann

Attorney and Partner
Dienemann Rechtsanwälte
Master of Pharma Business Administration

Dr. Alexander Frenzel

Business Excellence, Global Business Franchise Fertility
Merck Healthcare
Master of Pharma Business Administration

Dr. Marcus Gollub

Former President & Head of Region Europe
Merz Therapeutics
Master of Pharma Business Administration

Dr. Andreas Henschel

Head of Health Technology Assessment
Boehringer Ingelheim
Master of Pharma Business Administration

Prof. Dr. Aimo Kannt

Head of Drug Discovery and Preclinical Research
Fraunhofer Institute ITMP
Master of Pharma Business Administration

Nora Kessler

Partner & UPC Representative
BluePort Legal
Master of Pharma Business Administration

Dr. Edmund Kostewicz

Fraunhofer Institute for Translational Medicine and Pharmacology ITMP
Goethe University
Master of Pharma Business Administration

Dr. Markus König

Negotiation Lead
Abbvie
Master of Pharma Business Administration

Dr. Stephan Linden

Director Global Market Access
CSL Behring
Master of Pharma Business Administration

Prof. Dr. Jochen Maas

Vice President
House of Pharma & Healthcare

Dr. Ralf Mayr-Stein

Vorstandsmitglied / Senior Executive bei Viatris
Viatris Germany
Master of Pharma Business Administration

Dr. Matthias Meergans

General Manager for Research & Development
Verband Forschender Arzneimittelhersteller (VFA)
Master of Pharma Business Administration

Dr. Matthias Pfannkuche

Vice President & Head of Global Value Demonstration, Market Access & Pricing
Merck
Master of Pharma Business Administration

Dr. Martin Raditsch, PhD, RTTP

General Partner / Managing Director
CARMA FUND Management

Dr. Nico Riffel

Patent Attorney
Fuchs Patentanwälte Partnerschaft
Master of Pharma Business Administration

Dr. Otto Quintus Russe

Managing Director
House of Pharma & Healthcare
Master of Pharma Business Administration

Reinhold Schilling M.D.R.A

Head of Global Pharmacovigilance
Wörwag Pharma
Master of Pharma Business Administration

Prof. Dr. Manfred Schubert-Zsilavecz

President
House of Pharma & Healthcare

Dr. Andrea Schüssele

Director Regulatory Affairs
THE FORCE CT
Master of Pharma Business Administration

Jan Teckentrup

Senior Market Access Manager
GAIA

Dr. Jörg Janne Vehreschild

Founding Director Institute for Digital Medicine and Clinical Data Science & Medical Faculty
Goethe University
Master of Pharma Business Administration

Dr. Frank Wartenberg

President Central Europe
IQVIA
Executive Education

Dr. Markus Weigandt

EVP, Head DP R&D
Siegfried
Master of Pharma Business Administration

Prof. Dr. med Bianca Wittig

Medical Head Sanofi Specialty Care Germany, Switzerland, Austria & Country Medical Lead Germany
Sanofi
Master of Pharma Business Administration

FRIDAY TALKS

We regularly invite prominent guest speakers from various backgrounds to discuss current topics. While chatting with the experts in an intimate setting, students and alumni gain unique insights into how these experts deal with current challenges and make change happen. Students can usually look forward to two events per semester, which take place on Friday evenings after regular lectures and are followed by an opportunity to network with other participants.

Dr. Daniel Steiners

Roche Pharma AG
The Rules And Forces That Decide Where Innovation Happen – Why the Next Billion Won't Go Where You Think

Patrick van der Loo

Pfizer Germany
From Berlin to Washington: Building a Unified Pharma-Government Front

Prof. Dr. Jochen Maas

Sanofi
One Health – a New Approach for Future Thinking

Dr. Matthias Meergans

vfa
Pharma R&D 2035 – Shaping Germany’s Innovation Framework for the Future

Thibault Massart

AbbVie
Innovation & Bold Mindset

Christiane von der Eltz

Berlin-Chemie AG / Menarini
From Strategy to Impact: The Executive Board’s Role in Transformation Success

Dr. Ralf Angermund

J&J Innovative Medicine
Early Innovation Partnering between Academia, Start up, and Industry in Germany

Christoph Ruland

Boehringer Ingelheim
Bringing Innovation to Patients: Perspectives of a General Manager

Han Steutel

vfa
Technological Innovations, Technological Sovereignty
Master of Pharma Business Administration

Dr. Holger Bartz

Janssen-Cilag
Innovation in Digital Health

Dr. Alexander Horn

Eli Lilly
Innovative Leadership: How Modern Leadership Promotes Innovation and Increases Efficiency

Peter Goldschmidt

STADA Arzneimittel
Attitude Drives Performance

Dr. Theresa von Fugler

Nattermann & Cie.
From OTC to CHC - How The Self-Care Industry Has to Reinvent Itself

Victoria Williams

GlaxoSmithKline
Do We Still Need to Fight for Gender Equality in Business in 2022?

Dr. med. Christoph Bug

Veeva Systems
Data Driven Decision Making in Pharma Operations - Just Buzz or the New Norm?

Dr. Karsten Kissel

Gilead
CAR-T Cell Therapy - How Does Our Health Care System Cope with the Challenges of a Truly Innovative Health Technology?

Prof. Dr. Wolfram Carius

Bayer Pharma
Innovation through Cooperation in the Field of Cell and Gene Therapies

Prof. Helga Rübsamen-Schaeff

AiCuris
AiCuris - From a Biotech-Start Up to a Company in the Market

Prof. Dr. Frank Wartenberg

IQVIA
Emerging from the Pandemic: Priorities for Pharma in the New Normal

Dr. Christoph Bug

Janssen-Cilag
Disease Interception - Paradigm Shift in Health Care

Dr. Andreas Kress

Novartis
Gene Therpay - Beyond Today's Avenues

Prof. Dr. Hagen Pfundner

Roche
The Pandemic and the Health-Industry

Xavier Hormaechea

UCB
European Policy Healthcare Challenges

Klaus Falk

Samsung Bioepis
Samsung Bioepis - From Start-Up to a Leading Biopharmaceutical Company

Prof. Dr. Michael Popp

Bionorica
Herbal Medicines - More Modern than Ever

Prof. Dr. Klaus Cichutek

Paul Ehrlich Institut
Development and Regulation of Vaccines & Biomedicines

Dr. Martin Weiser

Bundesverband der Arzneimittelhersteller
Brexit and its Consequences for the Pharmaceutical Industry

Jim Baker

BioNTECH
Innovation. The Key to Individualized Therapy

Dr. Michael von Poncet

Janssen-Cilag
Importance of Collaborations for Pharmaceutical Research & Development Today… and Transformative Medical Innovations in Future

Prof. Dr. Almut Winterstein

University of Florida
Risk Evaluation and Mitigation Approaches of Marketed Drugs - Requirements and Challenges

Prof. Dr. Jochen Maas

Sanofi
Personalized Medizine - Hip or Hype?

Philipp Schulte-Noelle

Fresenius Kabi
M&A and Financing for Fresenius

PERSONAL DEVELOPMENT & SKILLS WORKSHOPS

In addition to the academic curriculum, we offer a series of Personal Development & Skills Workshops. These voluntary additional offerings focus on improving communication and leadership skills as well as selected technical topics.

COMPANY VISITS

Selected modules are taught in cooperation with pharmaceutical companies and some lectures take place on-site at the companies' premises. These company visits offer students an exclusive insight into corporate practice and are also an excellent platform for networking.

AACSB Standards

The Pharma MBA prepares professionals to take on leadership roles in today’s dynamic and complex business environment. The program is built around well-defined competency goals that shape both the curriculum and the learning experience. These goals are aligned with the academic standards of AACSB accreditation and reflect the real-world demands of the global healthcare and pharmaceutical industries.

Competency Goals 
CGBS-AOur graduates have acquired advanced theoretical knowledge.
CGBS-BOur graduates have acquired practice-oriented quantitative skills.
CGBS-COur graduates make ethically responsible decisions.
CGBS-DOur graduates have acquired advanced communication skills.
CGBS-FOur graduates have acquired practice-oriented leadership skills.

Read more about the AACSB standards and competency goals on their website